Transient Ischemic Attack: A Dangerous Harbinger and an Opportunity to Intervene

ABSTRACT

Transient ischemic attack (TIA) and ischemic stroke are both characterized by sudden onset of neurological symptoms due to focal cerebral ischemia, but they are distinguished by the duration of neurological symptoms, with TIA traditionally defined by resolution of symptoms within 24 hours and stroke reserved for symptoms of longer duration. Because TIA and ischemic stroke share etiologies, it is not surprising that the recommended evaluations and secondary prophylaxis are identical. However, recent studies suggest that optimal management of TIA and stroke may differ more than previously recognized. The short-term risk of ischemic stroke after TIA is very high, which may be because rapid recovery from neurological symptoms is indicative of reversal of ischemia and tissue still at risk. Regardless of whether residual symptoms or infarction are present, rapid recovery appears to predict a greater short-term risk of subsequent ischemic stroke and is more likely to reflect a distinct, unstable pathophysiology. Therefore, it may be more useful to characterize acute ischemic cerebrovascular syndromes on the basis of the extent of rapid recovery (i.e., on the inferred reversal of ischemia) than on the completeness of recovery at 24 hours. Patients with substantial rapid recovery may be those for whom acute intervention is most warranted.

KEYWORDS

Transient ischemic attack - stroke - prognosis - treatment

REFERENCES

• 1 Adams Jr H P, Brott T G, Crowell R M et al.. Guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.  Circulation. 1994;  90 1588-1601
• 2 Wolf P A, Clagett G P, Easton J D et al.. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the stroke council of the American Heart Association.  Stroke. 1999;  30 1991-1994
• 3 Feinberg W M, Albers G W, Barnett H J et al.. Guidelines for the management of transient ischemic attacks. From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association.  Circulation. 1994;  89 2950-2965
• 4 Albers G W, Hart R G, Lutsep H L, Newell D W, Sacco R L. AHA Scientific Statement. Supplement to the guidelines for the management of transient ischemic attacks: a statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association.  Stroke. 1999;  30 2502-2511
• 5 Culebras A, Kase C S, Masdeu J C et al.. Practice guidelines for the use of imaging in transient ischemic attacks and acute stroke: a report of the Stroke Council, American Heart Association.  Stroke. 1997;  28 1480-1497
• 6 Antithrombotic Trialists' Collaboration . Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.  BMJ. 2002;  324 71-86
• 7 Johnston S C. Recovery, instability, and transient ischemic attack.  Stroke Rounds. 2003;  1 1-6
• 8 Johnston S C. Clinical practice: transient ischemic attack.  N Engl J Med. 2002;  347 1687-1692
• 9 Ad Hoc Committee on Cerebrovascular Disease . A classification and outline of cerebrovascular diseases II.  Stroke. 1975;  6 564-616
• 10 Kimura K, Minematsu K, Yasaka M, Wada K, Yamaguchi T. The duration of symptoms in transient ischemic attack.  Neurology. 1999;  52 976-980
• 11 Waxman S G, Toole J F. Temporal profile resembling TIA in the setting of cerebral infarction.  Stroke. 1983;  14 433-437
• 12 Dennis M, Bamford J, Sandercock P, Molyneux A, Warlow C. Computed tomography in patients with transient ischaemic attacks: when is a transient ischaemic attack not a transient ischaemic attack but a stroke?.  J Neurol. 1990;  237 257-261
• 13 Warlow C. Transient ischaemic attacks: current treatment concepts.  Drugs. 1985;  29 474-482
• 14 Caplan L R. Are terms such as completed stroke or RIND of continued usefulness?.  Stroke. 1983;  14 431-433
• 15 Calandre L, Gomara S, Bermejo F, Millan J M, del Pozo G. Clinical-CT correlations in TIA, RIND, and strokes with minimum residuum.  Stroke. 1984;  15 663-666
• 16 Toole J F. The Willis lecture: transient ischemic attacks, scientific method, and new realities.  Stroke. 1991;  22 99-104
• 17 Albers G W, Caplan L R, Easton J D et al.. Transient ischemic attack: proposal for a new definition.  N Engl J Med. 2002;  347 1713-1716
• 18 Koudstaal P J, van Gijn J, Lodder J et al.. Transient ischemic attacks with and without a relevant infarct on computed tomographic scans cannot be distinguished clinically. Dutch Transient Ischemic Attack Study Group.  Arch Neurol. 1991;  48 916-920
• 19 Engelter S T, Provenzale J M, Petrella J R, Alberts M J. Diffusion MR imaging and transient ischemic attacks.  Stroke. 1999;  30 2762-2763
• 20 Eliasziw M, Streifler J Y, Spence J D, Fox A J, Hachinski V C, Barnett H J. Prognosis for patients following a transient ischemic attack with and without a cerebral infarction on brain CT. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group.  Neurology. 1995;  45 428-431
• 21 Koudstaal P J, Gerritsma J G, van Gijn J. Clinical disagreement on the diagnosis of transient ischemic attack: is the patient or the doctor to blame?.  Stroke. 1989;  20 300-301
• 22 Kraaijeveld C L, van Gijn J, Schouten H J, Staal A. Interobserver agreement for the diagnosis of transient ischemic attacks.  Stroke. 1984;  15 723-725
• 23 Johnston C M, Sidney S, Gress D R, Johnston S C. The prognostic value of head computerized tomography in TIA evaluation.  Neurology. 2001;  56 A159-A160
• 24 Daffertshofer M, Mielke O, Pullwitt A, Felsenstein M, Hennerici M. Transient ischemic attacks are more than “ministrokes”.  Stroke. 2004;  35 2453-2458
• 25 Eliasziw M, Kennedy J, Hill M D, Buchan A M, Barnett H J. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease.  CMAJ. 2004;  170 1105-1109
• 26 Johnston S C, Gress D R, Browner W S, Sidney S. Short-term prognosis after emergency-department diagnosis of transient ischemic attack.  JAMA. 2000;  284 2901-2906
• 27 Johnston S C, Sidney S, Bernstein A, Gress D R. A comparison of risk factors for recurrent TIA and stroke in patients with TIA.  Neurology. 2003;  60 280-285
• 28 Kidwell C S, Alger J R, Di Salle F et al.. Diffusion MRI in patients with transient ischemic attacks.  Stroke. 1999;  30 1174-1180
• 29 Purroy F, Montaner J, Rovira A, Delgado P, Quintana M, Alvarez-Sabin J. Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions.  Stroke. 2004;  35 2313-2319
• 30 Fiebach J B, Schellinger P D, Jansen O et al.. CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke.  Stroke. 2002;  33 2206-2210
• 31 Schulz U G, Briley D, Meagher T, Molyneux A, Rothwell P M. Diffusion-weighted MRI in 300 patients presenting late with subacute transient ischemic attack or minor stroke.  Stroke. 2004;  35 2459-2465
• 32 Gladstone D J, Kapral M K, Fang J, Laupacis A, Tu J V. Management and outcomes of transient ischemic attacks in Ontario.  CMAJ. 2004;  170 1099-1104
• 33 Whisnant J P, Matsumoto N, Elveback L R. Transient cerebral ischemic attacks in a community: Rochester, Minnesota, 1955 through 1969.  Mayo Clin Proc. 1973;  48 194-198
• 34 Dennis M, Bamford J, Sandercock P, Warlow C. Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project.  Stroke. 1990;  21 848-853
• 35 Biller J, Bruno A, Adams Jr H P et al.. A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks: a pilot study.  Stroke. 1989;  20 441-447
• 36 Putman S F, Adams Jr H P. Usefulness of heparin in initial management of patients with recent transient ischemic attacks.  Arch Neurol. 1985;  42 960-962
• 37 Humphrey P R, Marshall J. Transient ischemic attacks and strokes with recovery prognosis and investigation.  Stroke. 1981;  12 765-769
• 38 Coull A J, Lovett J K, Rothwell P M. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services.  BMJ. 2004;  328 326-328
• 39 Hill M D, Yiannakoulias N, Jeerakathil T, Tu J V, Svenson L W, Schopflocher D P. The high risk of stroke immediately after transient ischemic attack: a population-based study.  Neurology. 2004;  62 2015-2020
• 40 Kleindorfer D, Panagos P, Pancioli A et al.. Incidence and short-term prognosis of transient ischemic attack in a population-based study.  Stroke. 2005;  36 720-723
• 41 Lovett J K, Dennis M S, Sandercock P A, Bamford J, Warlow C P, Rothwell P M. Very early risk of stroke after a first transient ischemic attack.  Stroke. 2003;  34 e138-e140
• 42 Lisabeth L D, Ireland J K, Risser J M et al.. Stroke risk after transient ischemic attack in a population-based setting.  Stroke. 2004;  35 1842-1846
• 43 Rothwell P M, Warlow C P. Timing of TIAs preceding stroke: time window for prevention is very short.  Neurology. 2005;  64 817-820
• 44 Petty G W, Brown Jr R D, Whisnant J P, Sicks J D, O'Fallon W M, Wiebers D O. Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989.  Neurology. 1998;  50 208-216
• 45 Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Long-term risk of recurrent stroke after a first-ever stroke: the Oxfordshire Community Stroke Project.  Stroke. 1994;  25 333-337
• 46 Sacco R L, Shi T, Zamanillo M C, Kargman D E. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study.  Neurology. 1994;  44 626-634
• 47 Hankey G J, Jamrozik K, Broadhurst R J et al.. Long-term risk of first recurrent stroke in the Perth Community Stroke Study.  Stroke. 1998;  29 2491-2500
• 48 Moroney J T, Bagiella E, Paik M C, Sacco R L, Desmond D W. Risk factors for early recurrence after ischemic stroke: the role of stroke syndrome and subtype.  Stroke. 1998;  29 2118-2124
• 49 Lai S M, Alter M, Friday G, Sobel E. A multifactorial analysis of risk factors for recurrence of ischemic stroke.  Stroke. 1994;  25 958-962
• 50 Sacco R L, Foulkes M A, Mohr J P, Wolf P A, Hier D B, Price T R. Determinants of early recurrence of cerebral infarction: The Stroke Data Bank.  Stroke. 1989;  20 983-989
• 51 Hier D B, Foulkes M A, Swiontoniowski M et al.. Stroke recurrence within 2 years after ischemic infarction.  Stroke. 1991;  22 155-161
• 52 International Stroke Trial Collaborative Group . The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke.  Lancet. 1997;  349 1569-1581
• 53 CAST Collaborative Group . CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke.  Lancet. 1997;  349 1641-1649
• 54 The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators . Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial.  JAMA. 1998;  279 1265-1272
• 55 Kay R, Wong K S, Yu Y L et al.. Low-molecular-weight heparin for the treatment of acute ischemic stroke.  N Engl J Med. 1995;  333 1588-1593
• 56 Bath P M, Lindenstrom E, Boysen G et al.. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial.  Lancet. 2001;  358 702-710
• 57 Wiebers D O, Whisnant J P, O'Fallon W M. Reversible ischemic neurologic deficit (RIND) in a community: Rochester, Minnesota, 1955-1974.  Neurology. 1982;  32 459-465
• 58 Johnston S C, Leira E C, Hansen M D, Adams Jr H P. Early recovery after cerebral ischemia and risk of subsequent neurological deterioration.  Ann Neurol. 2003;  54 439-444
• 59 Johnston S C, Easton J D. Are patients with acutely recovered cerebral ischemia more unstable?.  Stroke. 2003;  34 2446-2452
• 60 Alexandrov A V, Felberg R A, Demchuk A M et al.. Deterioration following spontaneous improvement: sonographic findings in patients with acutely resolving symptoms of cerebral ischemia.  Stroke. 2000;  31 915-919
• 61 Grotta J C, Welch K M, Fagan S C et al.. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial.  Stroke. 2001;  32 661-668
• 62 Kang D W, Latour L L, Chalela J A, Dambrosia J, Warach S. Early ischemic lesion recurrence within a week after acute ischemic stroke.  Ann Neurol. 2003;  54 66-74
• 63 Aslanyan S, Weir C J, Johnston S C, Lees K R. Poststroke neurological improvement within 7 days is associated with subsequent deterioration.  Stroke. 2004;  35 2165-2170
• 64 Kirino T. Ischemic tolerance.  J Cereb Blood Flow Metab. 2002;  22 1283-1296
• 65 Moncayo J, de Freitas G R, Bogousslavsky J, Altieri M, van Melle G. Do transient ischemic attacks have a neuroprotective effect?.  Neurology. 2000;  54 2089-2094
• 66 Weih M, Kallenberg K, Bergk A et al.. Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain?.  Stroke. 1999;  30 1851-1854
• 67 Sitzer M, Foerch C, Neumann-Haefelin T et al.. Transient ischaemic attack preceding anterior circulation infarction is independently associated with favourable outcome.  J Neurol Neurosurg Psychiatry. 2004;  75 659-660
• 68 Wegener S, Gottschalk B, Jovanovic V et al.. Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study.  Stroke. 2004;  35 616-621
• 69 Johnston S C. Ischemic preconditioning from transient ischemic attacks? Data from the Northern California TIA Study.  Stroke. 2004;  35(suppl 1) 2680-2682
• 70 Rordorf G, Cramer S C, Efird J T, Schwamm L H, Buonanno F, Koroshetz W J. Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety.  Stroke. 1997;  28 2133-2138
• 71 Rao S V, Ohman E M, Granger C B et al.. Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes.  Am J Cardiol. 2003;  91 936-940
• 72 Maron D J, Fazio S, Linton M F. Current perspectives on statins.  Circulation. 2000;  101 207-213
• 73 Gubitz G, Counsell C, Sandercock P, Signorini D. Anticoagulants for acute ischaemic stroke.  Cochrane Database Syst Rev. 2002;  2 CD000024
• 74 Adams Jr H P. Emergent use of anticoagulation for treatment of patients with ischemic stroke.  Stroke. 2002;  33 856-861
• 75 Hart R G, Easton J D. Do we really need a better way to give heparin in acute cerebral ischemia?.  Stroke. 2002;  33 659-660
• 76 North American Symptomatic Carotid Endarterectomy Trial Collaborators . Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.  N Engl J Med. 1991;  325 445-453
• 77 European Carotid Surgery Trialists' Collaborative Group . Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST).  Lancet. 1998;  351 1379-1387